<qa>  What is the null hypothesis that therapy with Eplerenone over 12 months is associated withThe null hypothesis is that therapy with Eplerenone over 12 months is associated with an improvement in cardiopulmonary exercise capacity and furthermore that treatment is associated with improved clinical outcomes. 